• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Earnings roundup: Thermo Fisher revenue dips, but EPS jumps 15 percent

Earnings roundup: Thermo Fisher revenue dips, but EPS jumps 15 percent

February 3, 2011 By MassDevice staff

MassDevice.com Earnings Roundup

MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.

Here’s a quick rundown of a few releases over the past couple days:

Thermo Fisher revenue dips, but EPS jumps 15 percent
Thermo Fisher Scientific Inc. (NYSE:TMO) posted net income of $297.5 million, or 75 cents per diluted share, on revenue of $2.78 billion during the three months ended Dec. 31. That compares with net income of $273.3 million, or 65 cents per diluted share, on revenue of $2.84 billion during the same period last year.
Read more

Allergan profits, sales rise
Allergan Inc. (NYSE:AGN) reported net income of $263.1 million, or 85 cents per diluted share, on revenue of $1.31 billion during the three months ended Dec. 31. That compares with a profit of $221.5 million, or 72 cents per diluted share, on revenue of $1.22 billion during the same period last year.
Read more

Cardiovascular Systems’ increased sales temper losses
Cardiovascular Systems Inc. (NSDQ:CSII) reported a loss of $2.0 million, or 13 cents per diluted share, on sales of $18.8 million during the three months ended Dec. 31. That compares with a loss of $6.8 million, or 46 cents per diluted share, on sales of $15.1 million during the same period last year.
Read more

MKS Instruments profits rocket over 100 percent
MKS Instruments Inc. (NSDQ:MKSI) reported net income of $35.9 million or 70 cents per diluted share, on sales of $219.0 million during the three months ended Dec. 31. That compares with net income of $14.9 million, or 30 cents per diluted share, on sales of $142.8 million during the same period last year.
Read more

Hospira profits sink 37 percent after sales drop
Hospira Inc. (NYSE:HSP) recorded a profit of $60.6 million, or 36 cents per diluted share, on sales of $992.1 million during the three months ended Dec. 31. That compares with a profit of $96.7 million, or 58 cents per diluted share, on sales of $1.06 billion during the same period last year.
Read more

Affymetrix sales fall, but income rises
Affymetrix Inc. (NSDQ:AFFX) posted net income of approximately $4.0 million, or 6 cents per diluted share, on sales of $84.9 million during the three months ended Dec. 31. That compares with net income of $2.8 million, or 4 cents per diluted share, on sales of $88.9 million during the same period last year.
Read more

Filed Under: Business/Financial News, MassDevice Earnings Roundup, News Well Tagged With: Affymetrix Inc., Allergan, Cardiovascular Systems Inc., Thermo Fisher Scientific

More recent news

  • Data backs DermaSensor skin cancer detection device
  • GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software
  • Accelus wins FDA clearance for MRI compatibility of FlareHawk spinal implants
  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy